Blood-Sucking Parasites Could Revolutionize Treatment for Autoimmune Diseases

Researchers at Monash University identified a tick-derived evasin that binds both CC and CXC chemokines.

The evasin intercepts chemokine signals that normally recruit immune cells and trigger inflammation.

Because it targets multiple chemokine classes, the molecule could inform therapies for RA, MS, IBD and cancer.